iShares Biotechnology ETF $IBB Shares Bought by LPL Financial LLC

LPL Financial LLC raised its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 145.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 992,799 shares of the financial services provider’s stock after purchasing an additional 589,033 shares during the quarter. LPL Financial LLC owned about 2.01% of iShares Biotechnology ETF worth $167,555,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC boosted its holdings in shares of iShares Biotechnology ETF by 46,806.0% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 46,906 shares of the financial services provider’s stock valued at $7,927,000 after acquiring an additional 46,806 shares in the last quarter. Aster Capital Management DIFC Ltd purchased a new stake in shares of iShares Biotechnology ETF in the third quarter valued at about $1,907,000. Central Pacific Bank Trust Division boosted its holdings in shares of iShares Biotechnology ETF by 296,500.0% in the fourth quarter. Central Pacific Bank Trust Division now owns 14,830 shares of the financial services provider’s stock valued at $2,503,000 after acquiring an additional 14,825 shares in the last quarter. Tudor Investment Corp ET AL purchased a new stake in shares of iShares Biotechnology ETF in the third quarter valued at about $931,000. Finally, WorthPointe LLC purchased a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $1,424,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

IBB stock opened at $165.93 on Thursday. iShares Biotechnology ETF has a 52 week low of $123.61 and a 52 week high of $179.64. The company’s 50-day moving average price is $170.24 and its 200 day moving average price is $170.63.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were issued a dividend of $0.1218 per share. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.